Cargando…

Ligand‐independent EphA2 contributes to chemoresistance in small‐cell lung cancer by enhancing PRMT1‐mediated SOX2 methylation

Chemoresistance is the crux of clinical treatment failure of small‐cell lung cancer (SCLC). Cancer stem cells play a critical role in therapeutic resistance of malignant tumors. Studies have shown that the role of erythropoietin‐producing hepatocellular A2 (EphA2) in tumors is complex. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Shumei, Wang, Qiuping, Wen, Yang, Wang, Yu, Li, Man, Wang, Qiongyao, Peng, Juan, Guo, Linlang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986087/ https://www.ncbi.nlm.nih.gov/pubmed/36377249 http://dx.doi.org/10.1111/cas.15653

Ejemplares similares

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer
por: Fan, Jia, et al.
Publicado: (2018)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity
por: Guidetti, Lorenzo, et al.
Publicado: (2023)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

Spatial organization-dependent EphA2 transcriptional responses revealed by ligand nanocalipers
por: Verheyen, Toon, et al.
Publicado: (2020)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells
por: Tawadros, T, et al.
Publicado: (2012)

Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2
por: Baggio, Carlo, et al.
Publicado: (2022)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

Ligand Targeting of EphA2 Enhances Keratinocyte Adhesion and Differentiation via Desmoglein 1
por: Lin, Samantha, et al.
Publicado: (2010)

The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures
por: Singh, Deo R., et al.
Publicado: (2018)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression
por: Li, Shibao, et al.
Publicado: (2017)

Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling
por: Gao, Zicong, et al.
Publicado: (2021)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
por: Cioce, Mario, et al.
Publicado: (2021)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
por: Cui, Shuang, et al.
Publicado: (2021)

Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer
por: Mitra, Debarpan, et al.
Publicado: (2023)

EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria
por: Darling, Thayer K., et al.
Publicado: (2020)

A role of the SAM domain in EphA2 receptor activation
por: Shi, Xiaojun, et al.
Publicado: (2017)

Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
por: Wilson, Kalin, et al.
Publicado: (2021)

Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway
por: Xiang, Yi-Ping, et al.
Publicado: (2020)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway
por: Peng, Juan, et al.
Publicado: (2016)

Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
por: Zhao, Ping, et al.
Publicado: (2023)

Novel [(111)In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA2
por: Furukawa, Takenori, et al.
Publicado: (2023)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Author Correction: The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures
por: Singh, Deo R., et al.
Publicado: (2018)

Probing the effect of clustering on EphA2 receptor signaling efficiency by subcellular control of ligand-receptor mobility
por: Chen, Zhongwen, et al.
Publicado: (2021)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K
por: Wang, Hua, et al.
Publicado: (2016)

Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury
por: Thundyil, John, et al.
Publicado: (2013)

Structures of the EphA2 Receptor at the Membrane: Role of Lipid Interactions
por: Chavent, Matthieu, et al.
Publicado: (2016)

EphA2 is a functional receptor for the growth factor progranulin
por: Neill, Thomas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cn4trd4vvff2936dedvg53gnv5